We are live on ! Find out more
BL

Bleichroeder LP Portfolio holdings

AUM $579M
1-Year Est. Return 94.36%
This Fund
S&P 500
This Quarter Est. Return
-6.55%
1 Year Est. Return
+94.36%
3 Year Est. Return
+196.81%
5 Year Est. Return
+210.19%
10 Year Est. Return
AUM
$616M
AUM Growth
-$47.1M
Cap. Flow
+$2.74M
Cap. Flow %
0.45%
Top 10 Hldgs %
61.13%
Holding
110
New
18
Increased
5
Reduced
1
Closed
13

Sector Composition

1 Healthcare 25.33%
2 Financials 14.03%
3 Industrials 13.51%
4 Consumer Discretionary 10.47%
5 Materials 9.18%

Similar funds

Bleichroeder LP's Q3 2021 Portfolio in Review

As of Q3 2021, Bleichroeder LP held 110 positions worth $616M, down 7.1% from $663M the previous quarter. Its ten largest holdings account for 61% of the portfolio.

Bleichroeder LP's Q3 2021 filing shows 18 new, 5 increased, 1 reduced and 13 closed positions. Its largest new stake was Cue Health Inc. Common Stock: 1,000,000 shares worth $11.8M. The largest sale was Filana Therapeutics, an estimated $32M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 23% a quarter earlier, followed by Financials and Industrials.

  • Bleichroeder LP's largest Q3 2021 buy was Cue Health Inc. Common Stock: 1,000,000 shares worth $11.8M.
  • Bleichroeder LP added most to Royalty Pharma in Q3 2021, an estimated $35.6M increase.
  • Bleichroeder LP's biggest Q3 2021 reduction was Optimum Communications Inc, cutting an estimated $10.2M.
  • Bleichroeder LP fully exited Filana Therapeutics in Q3 2021, selling an estimated $32M.
  • Bleichroeder LP's ten largest holdings make up 61% of its $616M portfolio in Q3 2021.
  • Bleichroeder LP opened 18 new positions and closed 13 in Q3 2021.
  • Bleichroeder LP's portfolio value fell 7.1% quarter-over-quarter to $616M.

Based on Bleichroeder LP's 13F filing for Q3 2021, filed 15 Nov 2021.